Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,838,000 | 1,543,000 | 1,246,000 | 858,000 | 544,000 |
| Receivables | 386,000 | 374,000 | 392,000 | 339,000 | 402,000 |
| Inventories | 445,000 | 447,000 | 520,000 | 579,000 | 597,000 |
| Other current assets | 318,000 | 275,000 | 283,000 | 505,000 | 389,000 |
| TOTAL | $2,987,000 | $2,639,000 | $2,441,000 | $2,281,000 | $1,932,000 |
| Non-Current Assets | |||||
| PPE Net | 7,121,000 | 7,252,000 | 7,588,000 | 8,242,000 | 8,347,000 |
| Investments And Advances | 0 | 173,000 | 185,000 | 185,000 | 190,000 |
| Intangibles | 822,000 | 827,000 | 833,000 | 841,000 | 859,000 |
| Other Non-Current Assets | 2,123,000 | 2,133,000 | 2,115,000 | 159,000 | 131,000 |
| TOTAL | $10,066,000 | $10,385,000 | $10,721,000 | $9,427,000 | $9,527,000 |
| Total Assets | $13,053,000 | $13,024,000 | $13,162,000 | $11,708,000 | $11,459,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 201,000 | 167,000 | 141,000 | 108,000 | 80,000 |
| Accounts payable and accrued liabilities | 332,000 | 263,000 | 286,000 | 243,000 | 292,000 |
| Accrued Expenses | 214,000 | 311,000 | 195,000 | 279,000 | 199,000 |
| TOTAL | $916,000 | $911,000 | $749,000 | $863,000 | $809,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,778,000 | 9,356,000 | 9,365,000 | 7,304,000 | 7,129,000 |
| Other Non-Current Liabilities | 1,317,000 | 514,000 | 548,000 | 590,000 | 573,000 |
| TOTAL | $10,098,000 | $9,906,000 | $9,949,000 | $7,938,000 | $7,731,000 |
| Total Liabilities | $11,014,000 | $10,817,000 | $10,698,000 | $8,801,000 | $8,540,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | -1,927,000 | -1,746,000 | -1,497,000 | -696,000 | -686,000 |
| Other shareholders' equity | 418,000 | 411,000 | 413,000 | 416,000 | 417,000 |
| TOTAL | $2,039,000 | $2,207,000 | $2,464,000 | $2,907,000 | $2,919,000 |
| Total Liabilities And Equity | $13,053,000 | $13,024,000 | $13,162,000 | $11,708,000 | $11,459,000 |